Goldman Sachs’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,030,039
| Closed | -$28.4M | – | 5710 |
|
|
2021
Q2 | $28.4M | Sell |
1,030,039
-562,472
| -35% | -$15.5M | 0.01% | 1478 |
|
|
2021
Q1 | $26.3M | Buy |
1,592,511
+610,590
| +62% | +$10.1M | 0.01% | 1487 |
|
|
2020
Q4 | $18.1M | Sell |
981,921
-838,406
| -46% | -$15.5M | ﹤0.01% | 1634 |
|
|
2020
Q3 | $24.8M | Buy |
1,820,327
+1,533,312
| +534% | +$20.9M | 0.01% | 1330 |
|
|
2020
Q2 | $5.14M | Buy |
287,015
+232,984
| +431% | +$4.18M | ﹤0.01% | 2331 |
|
|
2020
Q1 | $539K | Sell |
54,031
-3,290
| -6% | -$32.8K | ﹤0.01% | 3460 |
|
|
2019
Q4 | $466K | Buy |
57,321
+30,185
| +111% | +$245K | ﹤0.01% | 3685 |
|
|
2019
Q3 | $269K | Sell |
27,136
-40,196
| -60% | -$398K | ﹤0.01% | 3825 |
|
|
2019
Q2 | $850K | Buy |
67,332
+41,897
| +165% | +$529K | ﹤0.01% | 3276 |
|
|
2019
Q1 | $259K | Buy |
25,435
+8,561
| +51% | +$87.2K | ﹤0.01% | 3791 |
|
|
2018
Q4 | $127K | Buy |
16,874
+173
| +1% | +$1.3K | ﹤0.01% | 3850 |
|
|
2018
Q3 | $167K | Sell |
16,701
-76,799
| -82% | -$768K | ﹤0.01% | 3854 |
|
|
2018
Q2 | $1.18M | Buy |
+93,500
| New | +$1.18M | ﹤0.01% | 3120 |
|